Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 11414 participants.
Also called NCT03264352
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 11,414 participants
- Sponsor
- XueQing Yu
- Registry
-
NCT03264352
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT03264352. Randomized; single masking; primary purpose treatment. Start 2018-02-01 (actual); primary completion 2028-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
- Acronym
- IPAD
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Adverse Event
- Condition
- Blood Pressure
- Condition
- Prehypertension
- Condition
- Cardiovascular Risk Factor
- Intervention (Drug)
- Allisartan Isoproxil
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Other)
- Standard treatment by current guideline
- Lead sponsor
- XueQing Yu
Record details
- Record id
cardio:ct-nct03264352- Content hash
6802babdd445448fa287b41efdf37a4518704a2fb5d9346b62c0d6fed0248e70